Up‐regulation of the inflammatory‐reparative phenotype in human prostate carcinoma
- 22 June 2009
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 69 (11), 1245-1255
- https://doi.org/10.1002/pros.20966
Abstract
BACKGROUND Recent studies have underlined the role of tumor cells in the endogenous synthesis of pro-inflammatory molecules. We tested whether malignant progression in prostate cancer was associated with the activation of a phenotype typical of the innate immune system. METHODS The expression of a set of molecules involved in tissue inflammation and repair was measured by real-time PCR and Western blot analysis in prostate samples in the absence or slight presence of a detectable leukocyte infiltrate. Whole tumor and non-tumor samples were analyzed in addition to laser-capture microdissected tumor and host epithelium. Receptor for advanced glycation end products, purine receptor, inducible enzymes cyclooxygenase-2 and nitric oxide synthase-2, pentraxin-3 and growth-survival factor receptors such as epithelial growth factor and estrogen α and β receptors were all studied. RESULTS A global survey approach showed an up-regulation in tumor samples of all of the studied genes, with the exception of ERβ. A laser-capture microdissection approach highlighted over-expression of pro-inflammatory molecules in each tumor sample examined. Nuclear translocation of nuclear factor-kB subunit p65 was observed in tumor tissues. CONCLUSIONS These data support the evidence that molecules typical of the innate immune system, similar to that of activated leukocytes, are produced by prostate epithelial cells and that their expression is up-regulated in malignant cells. We suggest that the observed pro-inflammatory and repair process activation may represent an important molecular mechanism in the progression of prostate cancer. Prostate 69:1245–1255, 2009.Keywords
Funding Information
- MIUR, Italy (COFIN 2006062242)
This publication has 27 references indexed in Scilit:
- The role of TLR activation in inflammationThe Journal of Pathology, 2007
- The role of the purinergic P2X7 receptor in inflammationJournal of Inflammation, 2007
- Interactions between Dietary Factors and Inflammation in Prostate CarcinogenesisPublished by Defense Technical Information Center (DTIC) ,2006
- Estrogenic Regulation of Host Immunity against an Estrogen Receptor–Negative Human Breast CancerClinical Cancer Research, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Alarmins: chemotactic activators of immune responsesCurrent Opinion in Immunology, 2005
- PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITYAnnual Review of Immunology, 2005
- Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammationGlycobiology, 2005
- An inflammatory linkNature, 2004
- Epidemiologic association between prostatitis and prostate cancerUrology, 2002